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A b s t r a c t  
The objective of the present investigation is to synthesize and characterize starch-silica 
coprecipitate and evaluate as tablet superdisintegrant.The starch-silica coprecipitate was 
synthesized by coprecipitation of silica on the surface of starch particles as reported by Rashid et al. 
The coprecipitate was characterized in terms of compressibility characteristics, Differential Scanning 
Calorimetry (DSC) and Fourier Transformed Infra Red Spectroscopy (FTIR). Fast dissolving tablets 
were then formulated by direct compression method using the different concentration of 
coprecipitate, crosscarmellose sodium (CCS) and crosspovidone (CP) as superdisintegrant. The 
tablets were evaluated for the disintegration time, hardness, friability, tensile strength, weight 
variation and in vitro release studies. The starch-silica coprecipitate showed better disintegration 
and compressibility characteristics as compared to the known superdisintegrants.  FTIR indicated 
the absence of any chemical reaction between the two species (starch and silica) during the process 
of coprecipitation. DSC studies showed there is no interaction between the drug and coprecipitate. 
Hausner’s ratio & Carr’s index value of (1.17 and 14.7 respectively) of coprecipitate suggested 
excellent flowability.  The coprecipitate was found to be effective at all the concentrations tested in 
the fast dissolving tablet formulation. Disintegration time (DT) of less than 30 seconds was observed 
in case of coprecipitate whereas higher DT values was observed with CCS and CP as 
superdisintegrants. Starch-silica coprecipitate can be utilized as a superdisintegrant in the 
pharmaceutical applications owing to better compressibility and release characteristics.     
Keywords:Coprecipitate, crosspvidone, Crosscarmellose sodium, flowability, compressibility, 
disintegration time. 
 
 
Introduction 
The focus on drug development costs is driving the industry to 
consider outsourcing, relocating production and sourcing 
ingredients from lower-cost locations. The major area of potential is 
the innovative, new excipients offered by various excipient 
suppliers enable the development of new dosage forms, improve 
efficiency and may reduce the cost of drugs. They offer 
opportunities to introduce new dosage forms, and thus facilitate the 
extension of patent life. The novel excipients include excipients for 
direct compression, fast dissolving tablets and controlled release 
etc [1]. Microcrystalline Cellulose (MCC) is the most useful 
filler/binder for direct compression. MCC also has some 
disintegrant and anti-adherent properties. Many MCC based, co-
processed excipients with improved functional properties such as 
compressibility and flowability have been studied [2]. Fast 
dissolving tablets are formulated to eliminate the swallowing 
difficulty and unpalatable taste which is primary limitation of the 
conventional formulations [3, 4]. The most common and simple 
approach used in the formulation of the orally disintegrating tablets 
is the use of superdisintegrants [5, 6]. Disintegrating agents 
promote the breakup of the formulation into smaller fragments. 
They should have poor solubility, poor gel formation, good 
hydration capacity and good molding and flow properties [7-10]. 
Starch is the most widely used disintegrant in the pharmaceutical 
industry and used in higher concentration for effective 
disintegration [10-11]. Superdisintegrants are used in the very 
small amount for rapid disintegration as they swell several times of 
their original size when placed in water while producing minimal 
viscosity effects [12]. Most widely used superdisintegrants are 
crosscarmellose, crosspovidone, and sodium starch glycolate.  
The major mechanisms for disintegration are swelling of 
disintegrant (most common in tablet disintegration), porosity, 
capillary action and chemical reaction [13-14]. But there are some 
of the limitations in the use of conventional superdisintegrants such 
as decrease in the liquid uptake rate of the sodium starch glycolate 
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and crosscarmellose sodium in the acidic medium and decrease in 
the degree of swelling of sodium starch glycolate and 
crosspovidone by the use of wet granulation method [15-17]. 
Efforts in the direction of novel excipients led to the development of 
chitosan-silicon dioxide coprecipitate and PVP crosslinked with 
glutaraldehyde as novel superdisintegrants with improved 
compressibility and compactability characteristics and optimal 
tabletting properties[18, 19]. The present study was intended to 
prepare coprecipitate of silicon dioxide and starch with the aim to 
explore industrial potential of starch as superdisintegrant over the 
conventional superdisintegrants. The coprecipitate was anyalyzed 
for surface characterization and flow properties. Starch-Silica 
coprecipitate was then incorporated in fast dissolving tablets using 
Nimesulide as model drug and evaluated for in vitro drug release in 
comparison with existing superdisintegrants (Crosspovidone and 
Cross carmellose sodium). 
Material and Methods  
Materials 
Nimesulide, Cross carmellose sodium and Cross povidone were 
received as gift samples from Park Pharmaceuticals, Baddi, India. 
Starch and silicon dioxide were kindly gifted by Helios 
Pharmaceuticals, Baddi, India. Talc and magnesium stearate were 
purchased from S. D. Fine Chemicals Ltd. Mumbai, India. All other 
chemicals and reagents were of analytical grade and were used as 
such.  
Methods 
Preparation of Starch–Silica Co-precipitate 
The coprecipitate was prepared by the method as reported by 
Rashid et al. Starch (50 g) was dispersed in 100 mL of 2 M hot 
(80ºC) HCl solution for 1 hr. Colloidal silicon dioxide (50 g) was 
dispersed in 100 mL of 2M NaOH solution to which 100 mL of 
distilled water was added under stirring until homogenization of the 
silica suspension was accomplished. The starch suspension was 
added gradually to the silica suspension at an approximate rate of 
100 mL/min under vigorous stirring which was proceeded for 1 hr 
at ambient temperature (25°C) after completion of addition. The pH 
of the mixture was kept not to exceed, through mixing, a pH range 
from 6.5 to 7.0 by adjustment with concentrated HCl. The product 
was washed with deionized water. Then the product was filtered 
out using 20–25 mm filter papers. The filtrate solution was clear as 
starch and/or silica particles cause turbidity when present. The 
product was filtered out, dried in the oven at 90ºC, and finally 
passed over a mesh of 425 mm size and kept for further testing 
and characterization of the obtained material.  
 
 
Evaluation of physical properties of co-precipitate 
Bulk density (Db) and Tapped density (Dt)  
It is the ratio of total mass of powder to the bulk volume (Vb) of 
powder. It was measured by pouring the weighed powder (M) into 
a measuring cylinder and initial weight was noted.  
Tapped density is the ratio of total mass of the powder to the 
tapped volume of the powder. Tapped volume was measured by 
tapping the powder for 100 times.  
Carr’s Compressibility Index (I)  
 It is expressed in percentage and is given by  
I = {(Dt – Db)/ Dt}*100 
Where, Dt is the tapped density of the powder and 
             Db is the bulk density of the powder 
Hausner Ratio  
Hausner ratio is an indirect index of ease of powder flow. It is the 
ratio of tapped density to bulk density. Lower hausner ratio (<1.25) 
indicates better flow properties than higher ones (>1.25). 
Characterization of Starch-Silica Coprecipitate 
Scanning Electron Microscopy (SEM) 
The surface morphology of the starch and silica particles was 
observed by the Scanning Electron Microscopy (SEM) (JSM. 6600, 
Jeol, Japan). Starch and Starch-Silica coprecipitate samples were 
mounted on Aluminium stubs and then coated with gold by 
sputtering at 1200 V, 20 Ma for 105 s using a vacuum coater. 
FTIR Spectroscopy  
Infrared spectroscopy was used to follow the molecular interaction 
between starch and silica. Samples of starch, silica, starch-silica 
coprecipitate, physical mixture of starch and silica at the mass ratio 
of 1:1 were mixed with dried KBr (1% w/w). Then a small portion of 
the mixture was compressed in a special die at 15000 pounds per 
square inch to yield a transparent disk. The disk was then held in 
the instrument beam for spectroscopic examination.  
X-Ray Diffraction 
The XRD patterns of starch–silica coprecipitate, starch, and silica 
were measured using X-ray diffractometer (X-pert PRO, 
Panalytical, Netherland)  using Ni-filtered, CuK α radiation, with a 
voltage of 40kV and 25mA current. The scanning rate employed 
was 10 min-1 over a 10 to 300 diffraction angle (2θ) range.  
Differential Scanning Calorimetry 
The DSC thermograms of the samples were obtained using 
Differential Scanning Calorimetry (DSC Q10V9.9 Build 303). 
Samples were sealed in 40µL aluminium pans. An identical empty 
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pan was used for the reference purpose. Nimesulide was 
physically mixed with Starch-Silica at the mass ratio of 1:1 and the 
mixtures were subjected to DSC studies. The scanning was 
performed under atmospheric conditions. A heating rate of 
100C/min was used for all samples. 
Formulation of Tablets by Direct Compression Method 
Nimesulide is used as a model drug for the formation of all batches 
of tablets. Twelve batches (B1-B12) of the fast disintegrating 
tablets were prepared by using crosscarmellose sodium, 
crosspovidone and starch-silica coprecipitate as superdisintegrants 
at different concentrations (1%, 5%, 10% and 20%), avicel as a 
filler and magnesium stearate as lubricant by direct compression 
method. The composition of the different batches is depicted in 
Table1. 
Physicochemical evaluation of tablets 
Disintegration Time 
Disintegration test of the tablet was measured by USP 
disintegration test apparatus, in water (37±2oC). Time in seconds 
was noted until complete disintegration of tablet.  
Weight Variation test 
Weight variation test was done as specified in official standards. 
Hardness 
Hardness of the tablet was measured by using the Monsanto tablet 
hardness tester. It is expressed in kg/cm2. 
Tensile Strength 
The tensile strength is the force required to break a tablet by 
compressing it in the radial direction and is measured using a 
monsanto hardness tester. Tensile strength for crushing (T) is 
calculated using equation: 
    T= 2F / pidt 
Where F is the crushing load, and d and t signify the diameter and 
thickness of the tablet respectively. 
Friability (F) 
Friability of the tablet was determined as specified in official 
standards using Roche friability test apparatus. A maximum loss of 
weight (from a single test or from the mean of the three tests) not 
greater than 1.0 % is acceptable.  
In vitro dissolution studies 
All tablet batches were subjected to the dissolution studies using 
USP II dissolution apparatus.  Alkaline Borate buffer (pH 8.4) (900 
ml) was used as a dissolution medium kept at a temperature of 
37ºC and stirred at 50 rpm. The aliquots (5 ml) were withdrawn at 
5, 10, 15, 30, 45 and 60 min and replaced with the fresh medium. 
The samples were analyzed for nimesulide content by UV 
spectrophotometer at 392nm [20]. 
Results and Discussion 
Physical properties of starch-silica coprecipitate such as bulk 
density, tapped density, carr’s index and hausner’s index were 
measured and compared with the other available commercial 
superdisintegrants. Bulk density and tapped density of the starch-
silica coprecipitate was found to be 0.75 and 0.88 g/mL 
respectively. Carrs’s index and hausner’s ratio of the starch-silica 
coprecipitate were 14.7 and 1.17 respectively indicating excellent 
flowability characteristics of the starch-silica coprecipitate. The 
Physical properties of the starch-silica coprecipitate were 
appreciable in comparison to crossspovidone and cross carmellose 
sodium as depicted in Table 2.        
Scanning Electron Microscopy (SEM) 
SEM micrographs of samples showed that the flat irregularly folded 
sharp edged surface structure of starch (Figure 1) has been 
transformed into three dimensional structure of starch-silica 
coprecipitate (Figure 2). The small size of the starch-silica 
coprecipitate particles suggested that silicon dioxide may have 
precipitated over the surface of starch. Moreover the 
coprecipitation of silica onto the surface of starch may result in 
filling of the folded edges of starch. The finding could be correlated 
to decrease in surface area of the starch-silica coprecipitate, as 
reported by Rashid et al.  
 
FTIR Spectroscopy 
The infra red spectrum analysis of starch, silica and starch-silica 
coprecipitate was performed for studying structural modifications 
and interaction between the reacting moieties. Starch showed 
absorption band at 1634 and 2839.39 cm-1 (Figure 3) and silica 
showed absorption band at 1119.15 cm-1 (Figure 4) which is due to 
Si-O-Si symmetrical stretching vibration. All these bands were 
identical in the starch-silica coprecipitate (Figure 5). The results 
suggested the absence of chemical reactivity between starch and 
silica when they undergo co-precipitation. Moreover both the 
excipients maintained their independent chemical properties while 
providing increased functional performance (in terms of 
superdisintegrant action) after the formation of the starch-silica 
coprecipitate.  
X-Ray Powder Diffraction 
 X-ray powder diffraction was performed to monitor the changes in 
crystallinity characteristics of the product when silica is 
coprecipitated over starch. Non crystalline materials usually exhibit 
broad maxima in their XRD spectra. A change in the crystalline 
characteristics was reported when silica is precipitated over the  
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Table1. Composition used for the preparation of different batches of the fast disintegrating tablets 
 
Ingredients B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 
Nimesulide 50 50 50 50 50 50 50 50 50 50 50 50 
Starch silica 
coprecipitate 
2.5 12.5 25 50 ---- ---- ---- ---- ---- ---- ---- ---- 
Cross Povidone ---- ---- ---- ---- 2.5 12.5 25 50 ---- ---- ---- ---- 
Crosscarmellose 
sodium 
---- ---- ---- ---- ---- ---- ---- ---- 2.5 12.5 25 50 
Magnesium 
Stearate 
2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
Talc 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
Avicel 192.5 182.5 170 145 192.5 182.5 170 145 192.5 182.5 170 145 
*all quantities are expressed in mg. 
 
Table 2. Comparison of physical properties of the starch- silica coprecipitate with other commercial superdisintegrants 
 
Physical property Starch silica co precipitate Cross povidone Cross Carmellose Sodium 
Bulk density 0.75±0.02 g/ml 0.54±0.02 g/ml 0.67±0.03 g/ml 
Tapped density 0.88±0.03 g/ml 0.67±0.02 g/ml 0.74 ±0.02 g/ml 
Carr’s Index 14.70±0.26 20.14±0.05 19.50±0.21 
Hausner’s Ratio 1.17±0.05 1.34±0.04 1.48 ±0.02 
Flowability Excellent Fairly passable flow Fairly passable flow 
 
Table 3. Physicochemical evaluation of the fast dissolving tablets of Nimesulide 
 
Formulation Hardness 
(Kg/cm2) 
Friability 
(%) 
Weight 
Variation 
(%) 
Disintegrat
ion Time 
(Sec.) 
Tensile 
Strength (T) 
(MNm-2) 
% Drug 
Release in (5 
minutes) 
B1 3.5±0.12 0.39 ±4.2 25±1.2 6.79±0.16 77.67±1.4 
B2 3.7±0.23 0.42 ±4.1 24±1.1 7.75±0.05 78.66±1.6 
B3 3.2±0.64 0.45 ±4.5 25±1.5 5.92±0.03 79.33±1.6 
B4 3.4±0.27 0.52 ±4.8 26±1.7 6.60±0.03 78.61±1.5 
B5 3.1±0.56 0.48 ±4.3 75±1.3 5.36±0.01 37.65±1.1 
B6 3.5±0.43 0.45 ±4.7 63±1.2 5.80±0.02 54.18±1.3 
B7 3.6±0.29 0.46 ±4.4 54±2.1 6.23±0.02 66.12±2.2 
B8 3.2±0.48 0.38 ±4.6 78±2.1 5.19±0.01 60.97±2.1 
B9 3.8±0.39 0.55 ±4.1 69±1.8 7.20±0.04 51.79±1.9 
B10 3.6±0.19 0.42 ±4.4 58±2.2 6.66±0.05 67.40±2.0 
B11 3.3±0.27 0.56 ±4.2 52 ±1.7 5.97±0.03 72.73±2.1 
B12 3.7±0.53 0.53 ±4.1 70±2.3 7.18±0.03 48.67±1.4 
 
 
 
 
 
 
Nagpal et al. International Journal of Drug Delivery 4 (2) 164-174 [2012] 
 
PAGE | 168 | 
 
 
 
 
 
                               
Figure 1. Scanning Electron Micrograph of starch 
 
 
 
 
Figure 2. Scanning Electron Micrograph of Starch-Silica coprecipitate 
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Figure 3. FTIR spectrum of starch 
 
 
 
Figure 4. FTIR spectrum of silicon dioxide 
 
 
Figure 5. FTIR spectrum of starch-silica coprecipitate 
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Figure 6. Overlay XRD spectrum of A. Silicon Dioxide B. Starch C. Starch-Silica coprecipitate 
 
 
 
Figure 7. DSC thermogram of pure drug nimesulide 
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Figure 8. DSC thermogram of starch-silica coprecipitate 
 
Figure 9. DSC thermogram of physical mixture of drug and coprecipitate in 1:1 
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Figure10. In vitro dissolution Profile of all formulations batches (B1-B12) 
 
 
starch.  Figure 6 shows the diffraction patterns of starch, silica and 
starch-silica coprecipitate. The amorphous form of the starch 
established partial crystalline characteristics on precipitation of the 
silica over the starch. Starch showed three broad peaks at 20.3, 
22.5 and 34.4 having peak areas 167.89, 379.89 and 62.91 
respectively, which may be due to the distributed crystal structure 
of the starch. XRD spectra of silica exhibited the presence of broad 
peak at 26.28. Appearance of two sharp and narrow peaks at 22.6 
and 34.3 with peak area 114.07 and 18.14 respectively in the XRD 
spectra of starch silica co precipitate point out towards the 
reduction of powder’s amorphous region and appearance of the 
crystalline characteristics.  
Differential scanning calorimetry  
Differential scanning calorimetry (DSC) is a technique for 
measuring the physical transformation of the drugs when they 
undergo phase transitions due to endothermic or exothermic heat 
flows. Nimesulide showed an endothermic heat flow at 152.5 ºC 
corresponding to melting with decomposition (Figure 7). Starch–
silica coprecipitate showed decomposition endothermic heat flow at 
a temperature range of 147.23 - 153.26 ºC (Figure 8). No shift in 
the decomposition temperature range of starch–silica coprecipitate 
and nimesulide endothermic peak when starch-silica coprecipitate 
was mixed with nimesulide at the mass ratio of 1:1, as observed by 
DSC thermogram (Figure 9).  This indicates the chemical 
compatibility of nimesulide with starch-silica and hence the 
absence of any new chemical entities.  
 
Physicochemical evaluation of tablets 
Tablets prepared with the starch-silica coprecipitate showed better 
disintegration characteristics as compared to tablets prepared 
using crosspovidone and crosscarmellose sodium (Table 3). DT 
value of less than 30 sec was observed at low concentration (1%) 
of the starch silica co precipitate whereas DT of more than 50 sec 
was observed with CCS and CP at higher concentrations (10%), 
suggesting better superdisintegrant action of coprecipitate over 
conventional superdisintegrants.  Moreover,  the DT was 
independent of concentration of coprecipitate (almost same at all 
concentrations) whereas in case of crosscarmellose sodium and 
crosspovidone, the DT value decreases with increase in 
concentration upto 10%, after that (at 20%) it increases. Hardness 
of all tablet batches was found to be almost same. All tablet 
batches passed the friability (% weight loss is < 1%) and weight 
variation test. The tensile strength was found to ranged from 5.92 
to 7.752 (B1 to B4), 5.199 to 6.230 (B5 to B8) and 5.971 to 7.203 
(B9 to B12) (Table 3). 
In vitro drug release  
In vitro dissolution profiles of prepared batches of FDTs using 
crosscarmellose sodium, crosspovidone and starch silica 
coprecipitate as superdisintegrants are depicted in Figure 10. 
Tablet containing starch-silica coprecipitate (batch B1-B4) 
exhibited > 70% release after 5 min at all concentrations (1-20%) 
whereas tablets containing CP and CCS as superdisintegrant 
(batch B5-B8, B9-B12 respectively) showed > 60% release at a 
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concentration of 10% indicating better disintegration and drug 
release characteristics caused by the coprecipitate over existing 
superdisintegrants. 
Conclusion 
In summary, starch-silica coprecipitate showed the improved 
characteristics as superdisintegrants as compared to the 
conventional superdisintegrants. The coprecipitate act as inert 
material with better compressibility characteristics over 
conventional superdisintegrants. Moreover no interaction with the 
drug particles as confirmed by DSC studies suggested that it can 
be used as an excipient in tablet dosage form. Better disintegration 
characteristics exhibited by coprecipitate over conventional 
superdisintegrants suggested that it can be commercially exploited 
for industrial purpose.  
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